Datasets:
record_id stringlengths 29 47 | title stringlengths 44 160 | year int64 2.01k 2.03k | journal_or_venue stringlengths 8 90 ⌀ | document_type stringclasses 2
values | nanobubble_vs_nanoparticle stringclasses 4
values | application_category stringclasses 2
values | abstract_or_summary stringlengths 719 26k | size_value stringlengths 3 30 | size_unit stringclasses 3
values | size_evidence_quote stringlengths 9 166 | zeta_potential_value stringlengths 2 12 | zeta_potential_unit stringclasses 2
values | zeta_potential_evidence_quote stringlengths 8 35 | stability_value stringclasses 8
values | stability_unit stringclasses 6
values | stability_evidence_quote stringclasses 9
values | payload_value stringlengths 3 50 | payload_unit stringclasses 2
values | payload_evidence_quote stringlengths 5 327 | loading_efficiency_value stringlengths 1 12 | loading_efficiency_unit stringclasses 4
values | loading_efficiency_evidence_quote stringlengths 10 71 | release_profile_value stringlengths 1 34 | release_profile_unit stringclasses 8
values | release_profile_evidence_quote stringlengths 12 131 | ambiguity_flag stringclasses 2
values | annotator_notes stringlengths 4 133 ⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
API_PubMed_10_1007_s12032_025_03200_7 | Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line. | 2,025 | Medical oncology (Northwood, London, England) | original | nanoparticle | biomedical/translational | Cisplatin remains one of the most widely used chemotherapeutic agents, yet its clinical efficacy is limited by poor tumor selectivity, dose-dependent toxicity, and the development of resistance. Silibinin, a hydrophobic natural compound with antioxidant and anticancer activity, has been proposed as a complementary agen... | 144, 164 | nm | "particle sizes of 144 nm (silibinin) and 164 nm (cisplatin)" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | cisplatin; silibinin | NOT_REPORTED | encapsulate cisplatin and silibinin individually | 81.2; 59.4 | % | encapsulation efficiencies of 81.2% and 59.4% | 53.77Ð81.95; 57.18Ð73.41; biphasic | % | Silibinin release increased from 53.77% to 81.95%... cisplatin release increased from 57.18% to 73.41%... biphasic release behavior | direct | null |
API_OpenAlex_10_2166_wqrj_2025_052 | Critical review of oxidant application and scalability for managing toxic <i>Microcystis</i> blooms in wastewater stabilisation ponds | 2,025 | Water Quality Research Journal | review | nanobubble | environmental/water | ABSTRACT Wastewater stabilisation ponds (WSPs) provide favourable conditions for cyanobacterial proliferation. Cyanobacterial toxins (cyanotoxins) pose a risk to human health, environmental flows, and recycled water schemes if not managed appropriately. Cyanotoxins are released predominantly during cyanobacterial cell ... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | hydrogen peroxide; ozone | NOT_REPORTED | hydrogen peroxide and ozone nanobubbles | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | payloads are hydrogen peroxide and ozone, but it doesnot have units like numeric measurements does |
API_OpenAlex_10_1111_iwj_12873 | Topical oxygen therapy & micro/nanobubbles: a new modality for tissue oxygen delivery | 2,018 | International Wound Journal | review | nanobubble | environmental/water | Up to 15 billion dollars of US health care expenditure each year is consumed by treatment of poorly healing wounds whose etiologies are often associated with aberrancies in tissue oxygenation. To address this issue, several modes of tissue oxygen delivery systems exist, including Hyperbaric Oxygen Therapy (HBOT) and To... | 100 to <1 | _m | "range anywhere from 100 _m to <1 _m in diameter" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | hours | time | "relatively stable for hours" | oxygen | NOT_REPORTED | "oxygen delivery to wounds" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | size and stability are general characteristics, not tied to a specific experiment. Payload (oxygen) inferred from Òoxygen delivery.Ó |
API_OpenAlex_10_1021_acs_biomac_5b01003 | PEGylated Silk Nanoparticles for Anticancer Drug Delivery | 2,015 | Biomacromolecules | original | nanoparticle | biomedical/translational | Silk has a robust clinical track record and is emerging as a promising biopolymer for drug delivery, including its use as nanomedicine. However, silk-based nanomedicines still require further refinements for full exploitation of their potential; the application of "stealth" design principals is especially necessary to ... | 104 ± 1.7 | nm | "We first generated B. mori derived silk nanoparticles by driving β-sheet assembly (size 104 ± 1.7 nm, zeta potential -56 ± 5.6 mV) using nanoprecipitation" | -56 ± 5.6 | mV | "zeta potential -56 ± 5.6 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | anticancer drugs | NOT_REPORTED | "anticancer drug delivery system" | >93 | % | "encapsulation efficiency (>93%)" | 14; pH-dependent | days | "pH-dependent release over 14 days" | direct | Encapsulation efficiency reported as threshold (>93%), not exact value. |
API_OpenAlex_10_1021_acs_nanolett_6b01411 | Cytosolic Delivery of Nanolabels Prevents Their Asymmetric Inheritance and Enables Extended Quantitative in Vivo Cell Imaging | 2,016 | Nano Letters | original | nanobubble | biomedical/translational | Long-term in vivo imaging of cells is crucial for the understanding of cellular fate in biological processes in cancer research, immunology, or in cell-based therapies such as beta cell transplantation in type I diabetes or stem cell therapy. Traditionally, cell labeling with the desired contrast agent occurs ex vivo v... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | fluorescent dextrans; quantum dots | NOT_REPORTED | "loading of fluorescent dextrans and quantum dots" | 50; 3 | fold | "50 and 3 times higher loading" | 2; 2 | months; weeks | "tracked for up to two months... compared to 2 weeks" | inferred | Loading expressed as fold-increase rather than percentage; ÒreleaseÓ interpreted as retention/visibility duration. |
API_OpenAlex_10_1080_12269328_2016_1153987 | The fundamental phenomena of nanobubbles and their behavior in wastewater treatment technologies | 2,016 | Geosystem Engineering | original | nanobubble | environmental/water | The importance of nanobubbles is widely acknowledged, particularly in terms of their role with respect to bubble size and stability. Nanobubbles are tiny spherical cap-shaped bubbles, and have several unique physical and mechanical characteristics. Longevity, virtual disappearance of buoyancy, high internal pressure, e... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen | NOT_REPORTED | "high oxygen dissolution rate" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | properties described qualitatively without measurable values |
API_OpenAlex_10_1021_acs_langmuir_8b03650 | pH-Responsive Oxygen Nanobubbles for Spontaneous Oxygen Delivery in Hypoxic Tumors | 2,019 | Langmuir | original | micro/nanobubble | biomedical/translational | Tumor hypoxia is a significant factor leading to the resistance of tumors to treatment, especially for photodynamic therapy and radiotherapy where oxygen is needed to kill cancer cells. Oxygen delivery agents such as oxygen-saturated perfluorocarbon nanoemulsions and lipid oxygen microbubbles have been employed to supp... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen | NOT_REPORTED | oxygen nanobubbles | 6 | fold | intratumoral oxygen level increased by 6-fold | burst; pH-responsive | NOT_REPORTED | abrupt burst release of oxygen in the mild acidic tumor microenvironment | inferred | Loading expressed as fold increase; release described qualitatively (burst, pH-responsive). |
API_PubMed_10_1080_03639045_2025_2562181 | Targeted delivery of resveratrol using PEGylated PLGA nanoparticles decorated with folic acid for cancer therapy: characterization, and | 2,025 | Drug development and industrial pharmacy | original | nanoparticle | biomedical/translational | This study aimed to develop, characterize, and evaluate resveratrol-loaded pegylated PLGA [poly (lactic-co-glycolic acid)] nanoparticles with folate conjugation for improved drug delivery and cytotoxic efficacy against MCF7 breast cancer cells. The significance of this drug delivery system is to enhance the wetting cha... | 332.1 | nm | "particle size 332.1 nm" | -24.6 | mV | "zeta potential -24.6 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | resveratrol | NOT_REPORTED | "resveratrol-loaded pegylated PLGA nanoparticles" | 78.65; 36.19 | % | "entrapment efficiency 78.65 ± 0.165%, and drug loading 36.19 ± 0.154%" | sustained | NOT_REPORTED | "sustained release" | direct | Entrapment efficiency and drug loading both reported; release qualitative only |
API_OpenAlex_10_1002_ange_201505817 | Stable Encapsulated Air Nanobubbles in Water | 2,015 | Angewandte Chemie | original | micro/nanobubble | environmental/water | Abstract The dispersion into water of nanocapsules bearing a highly hydrophobic fluorinated internal lining yielded encapsulated air nanobubbles. These bubbles, like their micrometerâsized counterparts (microbubbles), effectively reflected ultrasound. More importantly, the nanobubbles survived under ultrasonication 1... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | 100 | fold | "survived under ultrasonication 100 times longer" | air | NOT_REPORTED | "encapsulated air nanobubbles" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | Stability expressed as fold increase vs microbubbles; no absolute values reported |
API_PubMed_10_2147_DDDT_S296880 | Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma. | 2,021 | Drug design, development and therapy | original | nanobubble | biomedical/translational | Sonodynamic therapy (SDT) is considered a promising therapeutic strategy for the effective elimination of cancer cells. However, developing novel sonosensitizers with potentially high SDT efficacy remains a considerable challenge. Herein, we utilized near-infrared dye IR820 nanobubbles (NBs) combined with a dual PI3K/m... | 545.5 ± 93.1 | nm | "particle size ... 545.5±93.1 nm" | -5.19 ± 1.73 | mV | "zeta potential ... -5.19±1.73 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | IR820; PI-103 | NOT_REPORTED | "IR820 nanobubbles (NBs) combined with ... PI-103" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | Dual payload system (IR820 NB + PI-103); no loading or release values reported |
API_OpenAlex_10_31635_ccschem_019_20190010 | Oxygen Nanoshuttles for Tumor Oxygenation and Enhanced Cancer Treatment | 2,019 | CCS Chemistry | original | nanoparticle | environmental/water | Open AccessCCS ChemistryMINI REVIEW1 Aug 2019Oxygen Nanoshuttles for Tumor Oxygenation and Enhanced Cancer Treatment Liangzhu Fengâ , Oshra Betzerâ , Danlei Tao, Tamar Sadan, Rachela Popovtzer and Zhuang Liu Liangzhu Fengâ Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functi... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen | NOT_REPORTED | "oxygen nanoshuttles" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | multiple systems discussed without specific quantitative values |
API_OpenAlex_10_1021_acsami_5b07778 | A Novel Approach to Making the Gas-Filled Liposome Real: Based on the Interaction of Lipid with Free Nanobubble within the Solution | 2,015 | ACS Applied Materials & Interfaces | original | nanobubble | biomedical/translational | Nanobubbles with a size less than 1 μm could make a promising application in ultrasound molecular imaging and drug delivery. However, the fabrication of stable gas encapsulation nanobubbles is still challenging. In this study, a novel method for preparation of lipid- encapsulated nanobubbles was reported. The disperse... | 194.4 ± 6.6 | nm | "mean diameter of 194.4 ± 6.6 nm" | -25.2 ± 1.9 | mV | "zeta potential of -25.2 ± 1.9 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | gas | NOT_REPORTED | "gas-filled ultrasound-sensitive liposome" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | GU-liposome nanobubble system |
API_PubMed_10_1080_10837450_2021_1912090 | Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy. | 2,021 | Pharmaceutical development and technology | original | nanobubble | biomedical/translational | A combination of doxorubicin (DOX) and small interfering RNA (siRNA) is proven effective for the reverse of multidrug resistance. However, rapid degradation and poor cellular internalization of siRNA hinder their synergistic action. To improve the combination effect, asparagine-glycine-arginine peptide (NGR) -modified ... | 245 | nm | "Diameters of these NBs were about 245 nm" | -3 | mV | "zeta potentials were about -3 mV" | 24 | h | "stable during 24 h" | DOX; siRNA | NOT_REPORTED | "DOX and... siRNA" | >80 | % | "Encapsulation efficiencies (EE) of DOX exceeded 80%" | >80; <5 | % | "above 80% DOX was released... less than 5% without treatment" | direct | Ultrasound-triggered release |
API_OpenAlex_10_3390_molecules25173814 | Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents | 2,020 | Molecules | review | nanoparticle | environmental/water | In recent years, researchers focused their attention on mesoporous silica nanoparticles (MSNs) owing to the considerable advancements of the characterization methods, especially electron microscopy methods, which allowed for a clear visualization of the pore structure and the materials encapsulated within the pores, al... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | anti-cancer drugs; antibiotics; pesticides | NOT_REPORTED | "encapsulation and release of anti-cancer drugs... antibiotics, pesticides" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled; stimuli-responsive | NOT_REPORTED | "controlled release... under the action of specific triggering factors" | inferred | multiple applications and payloads described without quantitative values |
API_OpenAlex_10_1093_jmicro_dfp056 | Morphological study of acoustic liposomes using transmission electron microscopy | 2,009 | Journal of Electron Microscopy | original | microbubble-adjacent | biomedical/translational | Sonoporation is achieved by ultrasound-mediated destruction of ultrasound contrast agents (UCA) microbubbles. For this, UCAs must be tissue specific and have good echogenicity and also function as drug carriers. Previous studies have developed acoustic liposomes (ALs), liposomes that encapsulate phosphate buffer soluti... | 200 | nm | "ALs were approximately 200 nm in size" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | perfluoropropane (C3F8); phosphate buffer solution | NOT_REPORTED | "encapsulate phosphate buffer solution and perfluoropropane (C3F8) gas" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | Zeta described qualitatively (ÒneutralÓ) without numeric value; multi-phase system (gas + liquid) |
API_OpenAlex_10_62400_jbs_v5i3_7061 | Preparation of biocompatible nanobubbles carrying quercetin and their inhibitory effects on non-small-cell lung carcinoma | 2,022 | Journal of Biological Studies | original | nanobubble | environmental/water | Non-small-cell lung carcinoma (NSCLC), major lung cancer is currently considered one of the leading causes of mortality and has become a progressively serious global public health burden. However, the conventional drug delivery approaches were unable to efficiently inhibit the proliferation and metastasis of lung cance... | 0.149 | nm | "approximate size of NBs was 0.149 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | quercetin | NOT_REPORTED | "loading quercetin" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | ultrasound-triggered | NOT_REPORTED | "Ultrasound waves were used to stimulate... release" | inferred | null |
API_OpenAlex_10_1016_j_resenv_2025_100256 | Interfacial oxygen nanobubble for mitigating the methane emissions from aquatic ecosystems: A review | 2,025 | Resources Environment and Sustainability | review | nanobubble | environmental/water | Methane (CH 4 ) emissions from aquatic ecosystems, including wetlands, freshwater bodies, and rice paddies, contribute significantly to global warming due to CH 4 âs high global warming potential. Traditional CH 4 mitigation strategies, such as mechanical aeration, sediment capping, and vegetation management, face ch... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen | NOT_REPORTED | "oxygen nanobubbles" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled; slow | NOT_REPORTED | "slow, controlled oxygen release" | inferred | null |
API_OpenAlex_10_1155_2017_8234712 | Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel | 2,017 | International Journal of Biomaterials | original | nanoparticle | biomedical/translational | The formulation of a potential delivery system based on liposomes (Lips) formulated from soy lecithin (SL) for paclitaxel (PTX) was achieved (PTX-Lips). At first, PTX-Lips were prepared by thin film method using SL and cholesterol and then were characterized for their physiochemical properties (particle size, polydispe... | 131 ± 30.5 | nm | "particle size of 131 ± 30.5 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | paclitaxel | NOT_REPORTED | "paclitaxel" | 94.5 | % | "94.5 ± 3.2%" | 96 | h | "released up to 96 h" | direct | null |
API_OpenAlex_10_4103_mgmj_mgmj_59_23 | Nanobubbles: an emerging science in nanotechnology | 2,023 | MGM Journal of Medical Sciences | original | nanobubble | environmental/water | Abstract Nanobubbles (NBs) are a practical, safe, innovative science widely used in many fields as advanced aeration technology. These have nano-size, hollow, spherical cavities enclosed gas pouches in an aqueous solution with shell and core structure. The core comprises active ingredients to deliver the drug to the ta... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen; hydrogen; CO_; ozone | NOT_REPORTED | "The properties such as longevity, high internal pressure, large specific surface area in the nano range, virtual disappearance of buoyancy, and ability to dissolve gases namely oxygen, hydrogen, carbon dioxide, and ozone make it versatile and eco-friendly" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | null |
API_OpenAlex_10_3390_ijms17091440 | Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses | 2,016 | International Journal of Molecular Sciences | review | nanoparticle | biomedical/translational | Nanocarriers, due to their unique features, are of increased interest among researchers working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules, involving non-toxic biodegradable polymers, liposomes, solid lipid nanoparticles, and inorganic-organic nanomaterials, are among the most used carri... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | drugs; vitamins; peptides | NOT_REPORTED | " This review aims to summarize the "state of the art" of drug delivery carriers in nanosize, paying attention to their surface functionalization with ligands and other small or polymeric compounds so as to upgrade active and passive targeting, different release patterns as well as cell targeting and stimuli responsibi... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled; stimuli-responsive | NOT_REPORTED | "different release patterns" | inferred | null |
API_OpenAlex_10_1117_12_2214812 | Development and evaluation of a novel VEGFR2-targeted nanoscale ultrasound contrast agents | 2,016 | Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE | original | nanobubble | biomedical/translational | Recent literatures have reported that the targeted nanoscale ultrasound contrast agents are becoming more and more important in medical application, like ultrasound imaging, detection of perfusion, drug delivery and molecular imaging and so on. In this study, we fabricated an uniform nanoscale bubbles (257 nm with the ... | 257 | nm | "In this study, we fabricated an uniform nanoscale bubbles (257 nm with the polydispersity index of 0.458)" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | null |
API_OpenAlex_10_22159_ijap_2022v14i4_44388 | FORMULATION AND OPTIMIZATION OF CERITINIB LOADED NANOBUBBLES BY BOX-BEHNKEN DESIGN | 2,022 | International Journal of Applied Pharmaceutics | original | nanobubble | biomedical/translational | Objective: Ceritinib is an anaplastic lymphoma kinase (ALK) inhibitor used to treat lung cancer. In the current research, the ceritinib-loaded nanobubbles were prepared by using perfluorobutane for inner core and medium molecular weight chitosan for the shell. Methods: A 33Box-Behnken design was used to determine the i... | 150Ð200 | nm | "TEM images revealed the superficial morphology and core-shell structure of nanobubbles in the size range of 150-200 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | ceritinib | NOT_REPORTED | "ceritinib-loaded" | 79.12; 19.2 | % | "79.12% and 19.2%" | 95.67 | %/24h | "95.67% drug in 24h" | direct | Dual metrics |
API_PubMed_10_1021_acsptsci_5c00363 | Plant-Derived Exosome-Coated Niosome Oxygen Nanobubbles for the Mitigation of Ocular Ischemia. | 2,025 | ACS pharmacology & translational science | original | nanobubble | biomedical/translational | Ischemic and/or hypoxic ocular diseases lack adequate, effective mitigative approaches and an understanding of the fundamental causes of ischemia-induced tissue damage. In this work, we introduce a plant-derived exosome-coated niosome oxygen nanobubble (E-NON), consisting of a gaseous oxygen core encapsulated within du... | 85.6 ± 14.4 | nm | "The hydrodynamic diameter of conceived E-NONs is 85.6 ± 14.4 nm" | -19.3 ± 0.8 | mV | "É with a zeta of -19.3 ± 0.8 mV" | 3 | months | "stable up to 3 months" | oxygen | mg/L | "oxygen loading capacity of 56.4 ± 0.9 mg/L" | 56.4 ± 0.9 | mg/L | "56.4 ± 0.9 mg/L" | 16 | h | "release up to 16 h" | direct | High-quality data |
API_PubMed_10_1021_acs_molpharmaceut_5c01256 | Boosting Oral Chemotherapy Efficacy and Ameliorating Intestinal Dysbiosis via a Microfluidic-Engineered RGD-Targeted Nanoplatform against Breast Cancer. | 2,026 | Molecular pharmaceutics | original | nanoparticle | biomedical/translational | Doxorubicin (DOX) faces significant challenges in oral chemotherapy due to low intestinal permeability and extensive first-pass metabolism. We developed microfluidics-prepared RGD-modified solid lipid nanoparticles (MF-SLNs) to enhance oral anticancer efficacy and investigate their impact on gut microbiota. In vitro an... | 120 | nm | "²120 nm" | 20 | mV | "²20 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | doxorubicin | NOT_REPORTED | "DOX" | >80 | % | "EE > 80%" | slow; sustained | NOT_REPORTED | "slow and sustained" | inferred | Threshold values |
API_OpenAlex_10_1088_0957_4484_23_9_095102 | Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents | 2,012 | Nanotechnology | original | nanoparticle | environmental/water | Fibrin nanoconstructs (FNCs) were prepared through a modified water-in-oil emulsification-diffusion route without the use of any surfactants, resulting in a high yield synthesis of fibrin nanotubes (FNTs) and fibrin nanoparticles (FNPs). The fibrin nanoconstructs formed an aligned structure with self-assembled nanotube... | 250 | nm | "The fibrin nanoconstructs formed an aligned structure with self-assembled nanotubes with closed heads that eventually formed spherical nanoparticles of size ~250 nm" | -44 | mV | "zeta potential of -44 mV" | 200 | ¡C | "temperature stability up to 200 ¡C" | tacrolimus | NOT_REPORTED | "deliver tacrolimus" | 66 | % | "encapsulation efficiency of 66%" | 1 | week | "release over a period of one week" | direct | Strong dataset |
API_PubMed_10_1007_s13346_022_01185_8 | Exploring chitosan-shelled nanobubbles to improve HER2 + immunotherapy via dendritic cell targeting. | 2,022 | Drug delivery and translational research | original | nanobubble | biomedical/translational | Immunotherapy is a valuable approach to cancer treatment as it is able to activate the immune system. However, the curative methods currently in clinical practice, including immune checkpoint inhibitors, present some limitations. Dendritic cell vaccination has been investigated as an immunotherapeutic strategy, and nan... | 300 | nm | "dimensions of approximately 300 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | 6 | months | "stability up to 6 months" | DNA vaccine | NOT_REPORTED | "delivery of a DNA vaccine" | 82 | % | "encapsulation efficiency (82%)" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | Clean nanobubble system |
API_OpenAlex_10_3390_pharmaceutics10040242 | Diatoms Green Nanotechnology for Biosilica-Based Drug Delivery Systems | 2,018 | Pharmaceutics | review | nanoparticle | biomedical/translational | Diatom microalgae are the most outstanding natural source of porous silica. The diatom cell is enclosed in a three-dimensional (3-D) ordered nanopatterned silica cell wall, called frustule. The unique properties of the diatom frustule, including high specific surface area, thermal stability, biocompatibility, and tailo... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | drugs | NOT_REPORTED | "drug carrier systems" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled | NOT_REPORTED | "drug loading/release kinetics" | inferred | null |
API_OpenAlex_10_1186_s12951_023_01776_8 | Ultrasound targeted microbubble destruction-triggered nitric oxide release via nanoscale ultrasound contrast agent for sensitizing chemoimmunotherapy | 2,023 | Journal of Nanobiotechnology | original | microbubble-adjacent | biomedical/translational | Immunotherapy had demonstrated inspiring effects in tumor treatment, but only a minority of people could benefit owing to the hypoxic and immune-suppressed tumor microenvironment (TME). Therefore, there was an urgent need for a strategy that could relieve hypoxia and increase infiltration of tumor lymphocytes simultane... | 300 | nm | "size of about 300 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | paclitaxel; L-arginine | NOT_REPORTED | "co-deliver paclitaxel and L-arginine" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | ultrasound-triggered | NOT_REPORTED | "ultrasound-triggered drug release" | inferred | No quantitative loading |
API_PubMed_10_3389_fmed_2023_1136304 | Functional evaluation of constructed pseudo-endogenous microRNA-targeted myocardial ultrasound nanobubble. | 2,023 | Frontiers in medicine | original | nanobubble | biomedical/translational | Stem cell transplantation is one of the treatment methods for acute myocardial infarction (AMI). MicroRNA-1 contributes to the study of the essential mechanisms of stem cell transplantation for treating AMI by targeted regulating the myocardial microenvironment after stem cell transplantation at the post-transcriptiona... | 504.02 ± 36.94; 568.00 ± 37.39 | nm | "504.02 ± 36.94 nm... 568.00 ± 37.39 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | 1 | h | "did not change significantly within 1 h" | miRNA-1 | NOT_REPORTED | "carry naked miRNA-1" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | direct | Two particle sizes |
API_OpenAlex_10_7150_thno_43402 | Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy | 2,020 | Theranostics | original | microbubble-adjacent | biomedical/translational | Development of versatile nanoplatforms that simultaneously integrate therapeutic and diagnostic features for stimuli-responsive delivery to tumors remains a great challenge. In this work, we report a novel intelligent redox-responsive hybrid nanosystem composed of MnO<sub>2</sub> nanoparticles (NPs) and doxorubicin (DO... | 106.8 | nm | "size of 106.8 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | doxorubicin; MnO2 | NOT_REPORTED | "DOX/MnO2" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | redox-responsive | NOT_REPORTED | "trigger release... intracellular environment" | inferred | Qualitative release |
API_OpenAlex_10_1021_acs_molpharmaceut_3c00983 | Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer | 2,024 | Molecular Pharmaceutics | original | nanoparticle | biomedical/translational | This study aims to encapsulate gemcitabine (GEM) using a phospholipid complex (PLC) in lipid nanoparticles (NPs) to achieve several desirable outcomes, including high drug loading, uniform particle size, improved therapeutic efficacy, and reduced toxicities. The successful preparation of GEM-loaded lipid NPs (GEM-NPs) ... | 138.5 ± 6.7 | nm | "size of 138.5 ± 6.7 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | gemcitabine | NOT_REPORTED | "GEM-loaded" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | sustained | NOT_REPORTED | "sustained release behavior" | inferred | No % |
API_PubMed_10_1016_j_ijpharm_2026_126860 | Endogenous and exogenous stimuli-responsive nanoparticles in the diagnosis and treatment for atherosclerosis. | 2,026 | International journal of pharmaceutics | review | nanoparticle | biomedical/translational | Atherosclerosis (AS), a chronic inflammatory disease characterized by lipid deposition in the arterial wall, serves as the primary pathological basis for cardiovascular diseases that contribute significantly to global morbidity and mortality. Recent advances in nanotechnology have enabled the design of smart nanopartic... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | drugs | NOT_REPORTED | "targeted diagnosis and therapy" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled; stimuli-responsive | NOT_REPORTED | "controlled drug release" | inferred | null |
API_EuropePMC_10_1016_j_ijpharm_2009_07_010 | Preparation and characterization of dextran nanobubbles for oxygen delivery. | 2,009 | null | original | nanobubble | biomedical/translational | Dextran nanobubbles were prepared with a dextran shell and a perfluoropentan core in which oxygen was stored. To increase the stability polyvinylpirrolidone was also added to the formulation as stabilizing agent. Rhodamine B was used as fluorescent marker to obtain fluorescent nanobubbles. The nanobubble formulations s... | 500 | nm | "sizes of about 500nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxygen | NOT_REPORTED | "oxygen-filled nanobubbles" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | ultrasound-enhanced | NOT_REPORTED | "release kinetics enhanced after insonation" | inferred | Qualitative |
API_OpenAlex_10_1155_2014_689391 | Formulation Optimization of Erythromycin Solid Lipid Nanocarrier Using Response Surface Methodology | 2,014 | BioMed Research International | original | nanoparticle | biomedical/translational | In present work response surface methodology (RSM) using the miscellaneous design model was used to optimize formulations of erythromycin solid lipid nanocarriers (ERY-SLN). Two-factor three level factorial design was considered for optimization. There were three parameters, drug entrapment efficiency (EE), drug loadin... | 153.21 ± 2.31 | nm | "153.21 ± 2.31 nm" | -15.18 | mV | "zeta potential value of -15.18 mV" | 3 | months | "storage condition... 3 months" | erythromycin | NOT_REPORTED | "ERY-SLN" | 88.40; 29.46 | % | "88.40%... 29.46%" | 66.26 | %/24h | "66.26% over 24 h" | direct | Strong dataset |
API_OpenAlex_10_1039_d0tb00012d | Controlled drug release from polyelectrolyteâdrug conjugate nanoparticles | 2,020 | Journal of Materials Chemistry B | original | nanoparticle | environmental/water | Encapsulating drugs in functional nanoparticles provides controlled and targeted release of drugs. In this study, a general approach for encapsulating hydrophobic drugs in polyelectrolyte nanoparticles was developed for a controlled drug release. Gemcitabine (GEM), an anticancer drug for pancreatic ductal adenocarcinom... | 12; 30; 60 | nm | "12 nm, 30 nm and 60 nm" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | gemcitabine | NOT_REPORTED | "GEM nanoparticles" | 29.29; 9.44 | % | "29.29%... 9.44%" | 96 | h | "after 96 hour" | direct | Multi-size conditions |
API_OpenAlex_10_1038_s41598_020_65773_9 | Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo | 2,020 | Scientific Reports | original | nanoparticle | biomedical/translational | As one of the main components of Tripterygium wilfordii Hook F, celastrol (CSL) has significant antitumor activity, but its clinical application has been limited by its poor solubility, low oral bioavailability and systemic toxicity. In this study, celastrol nanosuspensions (CSL-NSps) were prepared using an antisolvent... | 147.9 | nm | "147.9 nm" | -19.2 | mV | "-19.2 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | celastrol | NOT_REPORTED | "celastrol nanosuspensions" | 98.18; 86.83 | % | "98.18% and 86.83%" | 69.2 | %/48h | "69.20% within 48 h" | direct | High loading |
API_PubMed_10_1039_d1ra04983f | Utilizing polymer-conjugate albumin-based ultrafine gas bubbles in combination with ultra-high frequency radiations in drug transportation and delivery. | 2,021 | RSC advances | original | nanobubble | biomedical/translational | The application of ultrafine bubbles as drug carriers in drug delivery is still in its developmental stage; it is important to obtain a thorough understanding of the factors affecting the formation and stability of drug carrier matrices. In this study, the polyethylene glycol (PEG)-conjugated human serum albumin (HSA)-... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | quercetin | NOT_REPORTED | "quercetin delivery" | 90 | % | "approximately 90%" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | Partial abstract |
API_PubMed_10_1016_j_envres_2024_118980 | Advancing nanobubble technology for carbon-neutral water treatment and enhanced environmental sustainability. | 2,024 | Environmental research | review | nanobubble | environmental/water | Gaseous nanobubbles (NBs) with dimensions ranging from 1 to 1000 nm in the liquid phase have garnered significant interest due to their unique physicochemical characteristics, including specific surface area, low internal gas pressure, long-term stability, efficient mass transfer, interface potential, and free radical ... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | gases | NOT_REPORTED | "delivery of gases" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | inferred | null |
API_PubMed_10_2174_0115680096414252251125053406 | Design of Experiments-Based Formulation and Optimization of Oxaliplatin-Loaded Solid Lipid Nanoparticles for the Management of Colorectal Cancer. | 2,026 | Current cancer drug targets | original | nanoparticle | biomedical/translational | Oxaliplatin is a third-generation platinum-based chemotherapeutic agent widely used for colorectal cancer treatment. However, its therapeutic application is limited by low solubility, systemic toxicity, and poor bioavailability. Solid lipid nanoparticles (SLNs) were prepared using a micro-emulsion technique and further... | 115.41 | nm | "115.41 nm" | 23.1 | mV | "+23.1 mV" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | oxaliplatin | NOT_REPORTED | "Oxaliplatin SLNs" | 92; 10.2 | % | "92% and 10.2%" | 97 | %/48h | "97% over 48 hours" | direct | Clean |
API_OpenAlex_10_1121_1_5101512 | Light, sound, nanobubbles: New approach to contrast-enhanced ultrasound and photoacoustic imaging | 2,019 | The Journal of the Acoustical Society of America | original | micro/nanobubble | biomedical/translational | To overcome the most significant deficiencies of conventional and contrast-enhanced ultrasound imagingâlow contrast and large size of microbubbles, we introduced new class of contrast agentsânanometer scale particles that are capable of escaping vascular compartments, penetrating into tissue, and then, once they re... | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | drugs | NOT_REPORTED | "therapeutic cargo" | NOT_REPORTED | NOT_REPORTED | NOT_REPORTED | controlled | NOT_REPORTED | "controlled drug delivery and release" | inferred | Conceptual |
NanoBubbleEval v1.0
⚠ For NeurIPS reviewers — use this Croissant URL
Please do NOT use the URL exposed by the "Use this dataset → Croissant" button at the top-right of this page. That URL triggers a known bug in
mlcroissant==1.0.16(the version pinned by the NeurIPS Croissant validator Space) and produces aFilterFileserror that does not reflect a problem with the dataset itself.Use this URL instead — copy the line below verbatim into the validator's "URL Input" tab:
https://huggingface.co/datasets/EliasHossain/nanobubbleeval/resolve/main/croissant.jsonThe same file is also available at
metadata/croissant.json— open that link to view the file in the HuggingFace viewer (theresolve/URL above is served astext/plainso a browser will display the JSON as text rather than rendering it; that is expected and does not affect the validator, which fetches the bytes programmatically).Equivalent code snippet for
mlcroissant:from mlcroissant import Dataset ds = Dataset(jsonld="https://huggingface.co/datasets/EliasHossain/nanobubbleeval/resolve/main/croissant.json") records = ds.records("gold-hard-records") # note: id has hyphens, not underscoresThis URL passes JSON Format ✓, Croissant Schema ✓, and Records Generation ✓ on the same validator the AC uses.
An evidence-grounded benchmark for schema extraction, numerical grounding, and evidence attribution in the nanobubble and nanocarrier literature.
Summary
NanoBubbleEval operationalises three failure modes of scientific information extraction as decomposed evaluation tasks over a shared record set:
- Schema-fill hallucination — emitting a value when the source is silent.
- Numerical grounding under unit normalisation — drifting between nm and µm, hours and days, percent and fraction.
- Verbatim evidence attribution — citing a span that genuinely contains the answer.
The benchmark contributes:
- a 18-field normalised schema with an explicit
NOT_REPORTEDconvention scored under abstention-calibrated F1, - a tolerance-bounded numerical match metric over canonicalised units that disentangles unit drift from value drift, and
- an answer–evidence consistency rate that detects cite-hallucination — predictions that emit a correct value paired with an unsupported span.
v1.0 release at a glance
- Final warehouse size: 51,566 deduplicated records (post-recovery, 2026-05 snapshot).
- Gold-hard tier containment: 40/40 records resolve into the released warehouse.
- Provenance branch: B — original 2026-03 warehouse unrecovered; May 2026 re-harvest merged with direct-identifier re-fetches for the 14 records the query-based re-harvest did not return.
- Abstract cross-check (X / Y / Z):
- X = 14 records: source-API abstract is byte-identical to the annotation-time abstract.
- Y = 19 records: differ only after Unicode/whitespace normalisation (mojibake repair, NFKC, whitespace collapse).
- Z = 7 records: source-side editorial revisions or mismatches (e.g., PubMed structured-abstract section labels added post-annotation).
- 14 + 19 + 7 = 40.
The full audit log lives in verification/ and is
machine-readable via verification/summary.json.
Annotation tiers
| Tier | Records | Annotators | Use | Status |
|---|---|---|---|---|
| Gold-hard (headline) | 40 | pre-specified blind dual-annotator protocol; v1.0 ships single-annotator-validated labels under that protocol; full dual annotation and IAA statistics planned for v1.1 | All headline metrics | v1.0 |
| Gold-lite extension | 460 (dev=50, test=410) | single-annotator | Internal robustness check; not used for any reported claim | v1.1 (scheduled) |
Schema
Six headline fields (numerical: size, zeta_potential, stability,
loading_efficiency; text: payload, release_profile) and twelve
provisional fields (bubble_type, material_identity,
application_category, generation_method, characterization_method,
medium_environment, outcome_claim, evidence_span, ambiguity_flag,
plus three additional unit slots).
Numerical headline fields carry a canonical unit (size: nm; zeta potential: mV; stability: h; loading efficiency: %) and a unit-synonym table. Out-of-vocabulary unit strings are flagged but never silently coerced.
Files in this release
v1.0 (shipped here)
| Path | Purpose |
|---|---|
warehouse/master_inventory.csv |
51,566-record deduplicated warehouse manifest (2026-05 snapshot, post-recovery) |
gold_hard/iaa_subset.csv |
40-record gold-hard tier with first-annotator labels |
predictions/regex-v1.csv |
B1 regex baseline predictions on gold-hard |
predictions/biobert-squadv2.csv |
B2 BioBERT-SQuAD-v2 predictions on gold-hard |
predictions/qwen25-7b-instruct.csv |
B3 Qwen2.5-7B-Instruct predictions on gold-hard |
verification/gold_hard_identifier_parse.csv |
DOI candidates parsed from each gold-hard record_id |
verification/gold_hard_containment_before_merge.csv |
Per-record match status against the May 2026 re-harvest (26/40 matched) |
verification/gold_hard_refetch_log.csv |
Source API + DOI candidate that resolved each of the 14 missing records |
verification/gold_hard_abstract_crosscheck.csv |
Per-record abstract cross-check (verbatim / normalised / source-side revision) |
verification/gold_hard_containment_after_merge.csv |
Post-merge containment confirming all 40 gold-hard records resolve into the released warehouse |
verification/summary.json |
Machine-readable summary of all recovery counts |
verification/abstract_mismatches.txt |
First 120 chars of each Z-bucket mismatch for manual review |
metadata/croissant.json |
Croissant 1.1 dataset metadata |
metadata/extraction_schema.json |
18-field schema specification |
metadata/data_quality_report.md |
Warehouse-level QC (deduplication, missing fields) |
splits/slice_summary.md |
Slice membership counts |
splits/leakage_report.md |
Disjointness audit across splits |
v1.1 (scheduled, regenerable from the released pipeline scripts)
| Path | Purpose |
|---|---|
data/curated/nanobubble_core_high_precision.csv |
8,006-record A1+A2 high-precision core |
data/gold/gold_annotation_set_v3.csv |
500-record gold pool (gold-hard ∪ 460-record gold-lite) |
data/tasks/ |
Three task-view CSV files (structured, numerical, evidence) |
data/splits/splits.json |
Deterministic dev/test split file |
Provenance and recovery audit
The original 2026-03 warehouse from which the gold-hard tier was sampled was destroyed in a project-deletion incident. Local recovery was exhausted (filesystem, git history, and HuggingFace dataset history were all checked). Rather than ship a warehouse from which the evaluation tier could not be derived, we re-anchored the warehouse to the gold-hard records by direct identifier lookup against the source APIs:
- 26 / 40 records were already present in the May 2026 query-based re-harvest (matched by DOI or normalised title).
- 14 / 40 records were missing from the re-harvest. For each missing
record, the canonical source-API identifier encoded in the gold-hard
record_id(12 PubMed DOIs, 27 OpenAlex DOIs, 1 Europe PMC DOI across the full tier) was used to re-fetch metadata directly via PubMed E-utilities (idconv→efetch), OpenAlex/works/doi:, or EuropePMC search-by-DOI. All 14 re-fetches succeeded. - After deduplication (DOI → PMID/PMCID → normalised title → URL), the
released warehouse contains 51,566 records and is a strict superset
of the gold-hard tier by
record_id(40/40 resolve directly via the containment audit inverification/gold_hard_containment_after_merge.csv). - Annotation-time abstracts from the gold-hard file are preserved verbatim in the warehouse for the 14 re-fetched rows; baseline predictions remain exactly reproducible from the released warehouse.
The full identifier-anchored recovery pipeline lives in the GitHub repo at
scripts/verification/
and is rerunnable end-to-end from a clean checkout.
Baselines
| Baseline | Macro Naive-F1 | Macro Acal-F1 [95% CI] | Num. match | A–E consistency |
|---|---|---|---|---|
| B1 Regex | 0.305 | 0.493 [0.434, 0.538] | 0.889 | 1.000 |
| B2 BioBERT-SQuAD-v2 | 0.378 | 0.545 [0.487, 0.588] | 0.727 | 1.000 |
| B3 Qwen2.5-7B-Instruct | 0.724 | 0.758 [0.700, 0.810] | 1.000 | 0.939 |
Bootstrap 95% CIs computed by record-level resampling with replacement
(n_boot=1000, seed=42).
Headline finding
On the gold-hard tier, B3 dominates B2 by 21.3 points and B1 by 26.5 points of macro Acal-F1, with non-overlapping CIs across all three baselines. Unit accuracy is 1.000 across all three baselines, indicating that the bottleneck is which property to extract rather than how to canonicalise its unit. B3's macro Acal-F1 falls from 0.786 on original-research abstracts to 0.449 on review-paper abstracts — a 33.7-point drop, more than twice the corresponding drop for B1 (12.6 points) or B2 (15.6 points), suggesting the LLM is more sensitive to review-paper paraphrase than the simpler baselines.
Versioning
The benchmark is versioned semantically. v1.0 ships the post-recovery
deduplicated warehouse manifest, the 40-record gold-hard tier, the three
baseline-prediction files, the gold-hard recovery audit logs
(verification/), the Croissant 1.1 metadata, the schema specification,
and the slice and leakage reports. v1.1 will add the 8,006-record
high-precision core, the 500-record gold pool, the 460-record gold-lite
extension tier, the three task-view CSVs, the deterministic splits.json,
finalised dual annotation on the gold-hard tier, an open-access full-text
gold subset under the same schema, and a same-family-larger ceiling
baseline plus a retrieval-augmented variant. Items in the v1.1 list are
regenerable end-to-end from the released pipeline scripts; we did not ship
them in v1.0 to keep the release scope strictly to what has been audited
and validated.
Code
The accompanying Python package, pipeline scripts, and unit-test suite are released at:
https://github.com/eliashossain001/nanobubbleeval
License
The dataset is released under CC BY-NC 4.0 (research use only). The codebase is released under MIT.
- Downloads last month
- 98